Jump Financial’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.28M | Sell |
456,601
-47,208
| -9% | -$443K | 0.05% | 455 |
|
|
2025
Q1 | $3.58M | Buy |
503,809
+141,172
| +39% | +$1M | 0.05% | 410 |
|
|
2024
Q4 | $4.23M | Buy |
362,637
+175,885
| +94% | +$2.05M | 0.09% | 299 |
|
|
2024
Q3 | $3.84M | Buy |
+186,752
| New | +$3.84M | 0.08% | 296 |
|
|
2024
Q2 | – | Sell |
-52,560
| Closed | -$1.45M | – | 2110 |
|
|
2024
Q1 | $1.45M | Buy |
+52,560
| New | +$1.45M | 0.04% | 596 |
|
|
2023
Q4 | – | Sell |
-14,295
| Closed | -$452K | – | 2079 |
|
|
2023
Q3 | $452K | Buy |
+14,295
| New | +$452K | 0.02% | 1076 |
|
|
2023
Q1 | – | Sell |
-67,192
| Closed | -$2.34M | – | 1909 |
|
|
2022
Q4 | $2.34M | Buy |
67,192
+58,840
| +705% | +$2.05M | 0.12% | 226 |
|
|
2022
Q3 | $467K | Sell |
8,352
-64,048
| -88% | -$3.58M | 0.02% | 921 |
|
|
2022
Q2 | $3.75M | Buy |
72,400
+27,846
| +62% | +$1.44M | 0.16% | 173 |
|
|
2022
Q1 | $3.24M | Buy |
44,554
+33,831
| +315% | +$2.46M | 0.14% | 180 |
|
|
2021
Q4 | $1.27M | Sell |
10,723
-1,077
| -9% | -$127K | 0.08% | 314 |
|
|
2021
Q3 | $1.58M | Buy |
+11,800
| New | +$1.58M | 0.11% | 199 |
|
|
2021
Q1 | – | Sell |
-5,400
| Closed | -$294K | – | 1178 |
|
|
2020
Q4 | $294K | Buy |
+5,400
| New | +$294K | 0.05% | 606 |
|